IE 11 is a very old browser and is not supported on this site.

Organic growth of net sales

Organic growth of net sales shows the development of net sales for the operating segments Products & Care and Logistics & IT excluding the effects of acquisitions, new license agreements, openings and closures of pharmacies (effect of net expansion). It provides a “like-for-like” comparison with previous periods. In the business area Retail (B2C), organic growth of net sales is calculated only including points of sales with a full year period comparison. In the business area Professionals (B2B), organic growth of net sales is calculated only including existing business activities with a full year period comparison. In order to show the impact of mandatory price reductions of medications reimbursed by health insurers on net sales transparently, organic growth of net sales is also disclosed without the effect of mandatory price reductions.

Organic growth of net sales first half of 2023

in thousand CHF

Retail (B2C)

Professionals (B2B)

Products & Care 1)

Wholesale

Logistics & IT Services

Logistics & IT 1)

Net sales

679,086

128,627

804,364

1,457,284

70,418

1,518,491

Change to previous period

2.1%

17.6%

4.2%

5.6%

10.4%

5.8%

 

 

 

 

 

 

 

Effect of net expansion

3,394 2)

7,208 3)

10,602

760 3)

760

In % of net sales of previous period

0.5%

6.6%

1.4%

0.0%

1.2%

0.1%

 

 

 

 

 

 

 

Net sales excluding effect of net expansion

675,691

121,419

793,762

1,457,284

69,658

1,517,731

Organic growth of net sales

1.6%

11.0%

2.8%

5.6%

9.2%

5.7%

 

 

 

 

 

 

 

Mandatory price reductions 4)

9,092

 

 

26,589

 

 

In % of net sales of previous period

1.4%

 

 

1.9%

 

 

 

 

 

 

 

 

 

Net sales excluding effect of net expansion and mandatory price reductions

684,783

 

 

1,483,873

 

 

Organic growth of net sales excluding price reductions

3.0%

 

 

7.5%

 

 

1) Including eliminations of intercompany net sales

2) The effect of net expansion is calculated only including point of sales without a full year period comparison (acquisitions, openings and closure of pharmacies)

3) The effect of net expansion is calculated only including business activities without a full year period comparison (acquisitions and new license agreements)

4) Mandatory price reductions of medications reimbursed by health insurers of the specialities list (SL/LS) released by the Federal Office of Public Health (FOPH), calculated based on volumes of previous period

Organic growth of net sales first half of 2023 Products & Care

in thousand CHF

Local Pharmacies

Pharmacies at Home

Retail (B2C) 1)

Products & Brands

Services for Professionals

Professionals (B2B) 1)

Net sales

640,151

39,060

679,086

89,998

38,623

128,627

Change to previous period

1.9%

4.6%

2.1%

19.8%

12.8%

17.6%

 

 

 

 

 

 

 

Effect of net expansion

2,525 2)

869 2)

3,394 2)

6,044 3)

1,164 3)

7,208 3)

In % of net sales of previous period

0.4%

2.3%

0.5%

8.0%

3.4%

6.6%

 

 

 

 

 

 

 

Net sales excluding effect of net expansion

637,626

38,191

675,691

83,954

37,460

121,419

Organic growth of net sales

1.5%

2.3%

1.6%

11.8%

9.4%

11.0%

 

 

 

 

 

 

 

Mandatory price reductions 4)

9,092

9,092

 

 

 

In % of net sales of previous period

1.4%

0.0%

1.4%

 

 

 

 

 

 

 

 

 

 

Net sales excluding effect of net expansion and mandatory price reductions

646,718

38,191

684,783

 

 

 

Organic growth of net sales excluding price reductions

2.9%

2.3%

3.0%

 

 

 

1) Including eliminations of intercompany net sales

2) The effect of net expansion is calculated only including point of sales without a full year period comparison (acquisitions, openings and closure of pharmacies)

3) The effect of net expansion is calculated only including business activities without a full year period comparison (acquisitions and new license agreements)

4) Mandatory price reductions of medications reimbursed by health insurers of the specialities list (SL/LS) released by the Federal Office of Public Health (FOPH), calculated based on volumes of previous period

Organic growth of net sales first half of 2022

in thousand CHF

Retail (B2C) 1)

Professionals (B2B)

Products & Care 1) 2)

Wholesale

Logistics & IT Services

Logistics & IT 2)

Net sales

665,192

109,341

771,689

1,379,426

63,794

1,434,631

Change to previous period 3)

2.5%

23.5%

5.2%

3.8%

26.2%

4.1%

 

 

 

 

 

 

 

Effect of net expansion

6,172 4)

13,467 5)

19,639

In % of net sales of previous period

1.0%

15.2%

2.7%

0.0%

0.0%

0.0%

 

 

 

 

 

 

 

Net sales excluding effect of net expansion

659,020

95,874

752,050

1,379,426

63,794

1,434,631

Organic growth of net sales 3)

1.5%

8.3%

2.5%

3.8%

26.2%

4.1%

 

 

 

 

 

 

 

Mandatory price reductions 6)

7,262

 

 

26,387

 

 

In % of net sales of previous period

1.1%

 

 

2.0%

 

 

 

 

 

 

 

 

 

Net sales excluding effect of net expansion and mandatory price reductions

666,282

 

 

1,405,813

 

 

Organic growth of net sales excluding price reductions 3)

2.6%

 

 

5.8%

 

 

1) Figures restated (refer to note 4 of the Consolidated interim financial statements)

2) Including eliminations of intercompany net sales

3) Growth rate includes minor change in segment reporting structure: adjusted growth rate on a comparable basis would be 1.8% lower for Retail (B2C), 1.6% lower for Products & Care and 0.7% higher for Wholesale and Logistics & IT

4) The effect of net expansion is calculated only including point of sales without a full year period comparison (acquisitions, openings and closure of pharmacies)

5) The effect of net expansion is calculated only including business activities without a full year period comparison (acquisitions and new license agreements)

6) Mandatory price reductions of medications reimbursed by health insurers of the specialities list (SL/LS) released by the Federal Office of Public Health (FOPH), calculated based on volumes of previous period

Organic growth of net sales first half of 2022 Products & Care

in thousand CHF

Local Pharmacies

Pharmacies at Home 1)

Retail (B2C) 1) 2)

Products & Brands

Services for Professionals

Professionals (B2B) 2)

Net sales

627,947

37,349

665,192

75,097

34,244

109,341

Change to previous period 3)

1.8%

15.9%

2.5%

26.0%

18.3%

23.5%

 

 

 

 

 

 

 

Effect of net expansion

6,172 4)

- 4)

6,172 4)

7,721 5)

5,745 5)

13,467 5)

In % of net sales of previous period

1.0%

0.0%

1.0%

13.0%

19.9%

15.2%

 

 

 

 

 

 

 

Net sales excluding effect of net expansion

621,774

37,349

659,020

67,375

28,499

95,874

Organic growth of net sales 3)

0.8%

15.9%

1.5%

13.0%

–1.6%

8.3%

 

 

 

 

 

 

 

Mandatory price reductions 6)

7,262

7,262

 

 

 

In % of net sales of previous period

1.2%

0.0%

1.1%

 

 

 

 

 

 

 

 

 

 

Net sales excluding effect of net expansion and mandatory price reductions

629,036

37,349

666,282

 

 

 

Organic growth of net sales excluding price reductions 3)

2.0%

15.9%

2.6%

 

 

 

1) Figures restated (refer to note 4 of the Consolidated interim financial statements)

2) Including eliminations of intercompany net sales

3) Growth rate includes minor change in segment reporting structure: adjusted growth rate on a comparable basis would be 26.5% lower for Pharmacies at Home and 1.8% lower for Retail (B2C)

4) The effect of net expansion is calculated only including point of sales without a full year period comparison (acquisitions, openings and closure of pharmacies)

5) The effect of net expansion is calculated only including business activities without a full year period comparison (acquisitions and new license agreements)

6) Mandatory price reductions of medications reimbursed by health insurers of the specialities list (SL/LS) released by the Federal Office of Public Health (FOPH), calculated based on volumes of previous period

Galenica verwendet Cookies, um die Funktionen der Website zu optimieren und Ihnen das bestmögliche Erlebnis zu gewährleisten. Gebrauch von Cookies & Disclaimer